We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
IOLCP.NSE

Price
83.08
Stock movement down
-0.89 (-1.06%)
Company name
IOL Chemicals and Pharmaceuticals Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
24.39B
Ent value
30.73B
Price/Sales
1.12
Price/Book
1.39
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
21.05
Forward P/E
10.44
PEG
-
EPS growth
-44.16%
1 year return
8.40%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-12

DIVIDENDS

IOLCP.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E21.05
Price to OCF13.65
Price to FCF-
Price to EBITDA12.03
EV to EBITDA15.16

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.12
Price to Book1.39
EV to Sales1.42

FINANCIALS

Per share

Loading...
Per share data
Current share count293.53M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)7.96

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash273.00M
Net receivables5.23B
Total current assets11.41B
Goodwill0.00
Intangible assets139.50M
Property, plant and equipment11.93B
Total assets24.13B
Accounts payable3.56B
Short/Current long term debt0.00
Total current liabilities5.74B
Total liabilities6.62B
Shareholder's equity17.51B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open84.47
Daily high84.85
Daily low82.60
Daily Volume690K
All-time high175.88
1y analyst estimate110.00
Beta0.07
EPS (TTM)-
Dividend per share0.00
Ex-div date18 Feb 2025
Next earnings date10 Feb 2026

Downside potential

Loading...
Downside potential data
IOLCP.NSES&P500
Current price drop from All-time high-52.76%-1.08%
Highest price drop-66.26%-19.00%
Date of highest drop9 Apr 20258 Apr 2025
Avg drop from high-52.22%-2.64%
Avg time to new high-6 days
Max time to new high295 days89 days
COMPANY DETAILS
IOLCP.NSE (IOL Chemicals and Pharmaceuticals Limited) company logo
Marketcap
24.39B
Marketcap category
Large-cap
Description
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, and paracetamol. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-epileptic, anti-hypertensive, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.
Employees
2891
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found